Gary P. Wormser

Active 1979–2024

Also published as
GARY P. WORMSER · Gary P Wormser
133
Papers
24,243
Citations
92
h-index
132
i10-index

Citations

Citations per year for Gary P. Wormser1980: 2 citations1981: 3 citations1982: 21 citations1983: 75 citations1984: 70 citations1985: 45 citations1986: 44 citations1987: 45 citations1988: 28 citations1989: 28 citations1990: 25 citations1991: 12 citations1992: 17 citations1993: 20 citations1994: 19 citations1995: 44 citations1996: 53 citations1997: 74 citations1998: 74 citations1999: 88 citations2000: 96 citations2001: 112 citations2002: 105 citations2003: 145 citations2004: 102 citations2005: 139 citations2006: 124 citations2007: 87 citations2008: 142 citations2009: 140 citations2010: 124 citations2011: 152 citations2012: 134 citations2013: 114 citations2014: 174 citations2015: 147 citations2016: 154 citations2017: 127 citations2018: 98 citations2019: 384 citations2020: 586 citations2021: 400 citations2022: 310 citations2023: 208 citations2024: 329 citations2025: 92 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,853 citing papers, 45.5% of this breakdownGermany: 177 citing papers, 4.3% of this breakdownFrance: 166 citing papers, 4.1% of this breakdownUnited Kingdom: 163 citing papers, 4% of this breakdownCanada: 147 citing papers, 3.6% of this breakdownNetherlands: 130 citing papers, 3.2% of this breakdownChina: 88 citing papers, 2.1% of this breakdownItaly: 81 citing papers, 2% of this breakdownSweden: 76 citing papers, 1.9% of this breakdownSpain: 66 citing papers, 1.6% of this breakdownSwitzerland: 61 citing papers, 1.5% of this breakdownAustria: 56 citing papers, 1.4% of this breakdown
0%45.5%Other 24.8%

Fields

  • Immunology and Microbiology60.8%
  • Medicine31.5%
  • Biochemistry, Genetics and Molecular Biology3%
  • Agricultural and Biological Sciences1.3%
  • Health Professions0.7%
  • Neuroscience0.4%
  • Other2.3%

Topics

  • Vector-borne infectious diseases19%
  • Viral Infections and Vectors13.3%
  • Vector-Borne Animal Diseases5.7%
  • Mosquito-borne diseases and control3.5%
  • Dermatological diseases and infestations2.6%
  • Antimicrobial Resistance in Staphylococcus2.2%
  • Other53.7%

Coauthors

All papers

Open in search
  1. Lyme borreliosis

    Authors: , , , , , , , - Nature Reviews Disease Primers 2016 cited by 852

  2. Lyme borreliosis

    Authors: , , , - The Lancet 2011 cited by 1,199

  3. Comparison of Lyme Disease in the United States and Europe

    Authors: , , - Emerging infectious diseases 2021 cited by 277

  4. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 2,100

  5. Multistate Infestation with the Exotic Disease–Vector Tick Haemaphysalis longicornis — United States, August 2017–September 2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Yabsley, William Halperin - MMWR Morbidity and Mortality Weekly Report 2018 cited by 249

  6. Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after anIxodes scapularisTick Bite

    Authors: , , , , , , , , , , - New England Journal of Medicine 2001 cited by 511

  7. Whole genome sequencing of human Borrelia burgdorferi isolates reveals linked blocks of accessory genome elements located on plasmids and associated with human dissemination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2023 cited by 51

  8. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizaveta E Vaysbrot, Gary P Wormser, Lawrence S Zemel - Arthritis & Rheumatology 2020 cited by 350

  9. A Critical Appraisal of “Chronic Lyme Disease”

    Authors: , , , , , - New England Journal of Medicine 2007 cited by 577

  10. First Recognized Human Bite in the United States by the Asian Longhorned Tick, Haemaphysalis longicornis

    Authors: , , , , , , - Clinical Infectious Diseases 2019 cited by 106

  11. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizaveta E. Vaysbrot, Gary P. Wormser, Lawrence Zemel - Neurology 2020 cited by 68

  12. Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone

    Authors: , , , - IDCases 2022 cited by 38

  13. MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 337

  14. An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia

    Authors: , , , , , , , , , , - New England Journal of Medicine 1981 cited by 1,430

  15. Diagnosis of Lyme Borreliosis

    Authors: , , , - Clinical Microbiology Reviews 2005 cited by 739

  16. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis

    Authors: , , , - JAMA 2016 cited by 332

  17. Temporal Relation between Ixodes scapularis Abundance and Risk for Lyme Disease Associated with Erythema Migrans

    Authors: , , , , , , - American Journal of Epidemiology 1999 cited by 164

  18. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

    Authors: , , , , , , - Brain Behavior and Immunity 2010 cited by 90

  19. A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease

    Authors: - Diagnostic Microbiology and Infectious Disease 2021 cited by 33

  20. Persistent and Relapsing Babesiosis in Immunocompromised Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2007 cited by 353

  21. Differentiation of Reinfection from Relapse in Recurrent Lyme Disease

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 135

  22. Emergence of Resistance to Azithromycin‐Atovaquone in Immunocompromised Patients withBabesia microtiInfection

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 130

  23. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 102

  24. Rejection of the name Borreliella and all proposed species comb. nov. placed therein

    Authors: , , , , , , , , , , , , , , , , , , - INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 2020 cited by 36